19 Jan 2018 | 11:38 PM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
1,025.00
19.25
(1.92 %)
19 Jan 2018 | 03:41 PM
Change company
  • Open (Rs)
    1,006.00
  • Prev. close (Rs.)
    1,005.75
  • High (Rs.)
    1,028.91
  • Low (Rs.)
    1,003.05
  • 52W H (Rs.)
    1,080.00
  • 52W L (Rs.)
    581.25
  • Volume
    27906
  • MCap (Rs in Cr.)
    18,909.72
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
27.88
Operating Margin (%)
33.82
Gross Profit Margin (%)
31.13
Net Profit Margin (%)
24.05
Total Debt/Equity
0.13
Dividend payout Ratio (Net Profit)
29.13
Earning Retention Ratio
70.80

News

18 Dec 2017 - 16:02:00-Natco Pharma said that it has launched a generic version of Tenofovir Alafenamide TAF 25 mg a once-d...
14 Dec 2017 - 14:35:00-Shares of Natco Pharma continued gaining streak on Thursday and rallied nearly 6 per cent on the Bom...
03 Nov 2017 - 12:22:00-Drug maker Natco Pharma said that its marketing partner Alvogen has received the final approval fir...
02 Nov 2017 - 16:49:00-Natco Pharma today reported a 27.49 per cent rise in consolidated net profit to Rs 84...

Announcements

10-Jan-2018
Natco Pharma - Shareholding for the Period Ended December 31 2017
10-Jan-2018
Natco Pharma - Statement Of Investor Complaints Letter
18-Dec-2017
Natco Pharma - Press Release
18-Dec-2017
Natco Pharma - Press Release / Media Release
15-Dec-2017
Natco Pharma - Committee Meeting Updates

Religare Research

18 Jan 2018 | 10:09 AM
The rupee ended at 63.88 to a dollar from 64.03 at the previous close. It rose 0.23% intraday, marki...
18 Jan 2018 | 10:00 AM
Highlights: • Agri markets kept trading with high volatility as the uptrend got limited from i...
18 Jan 2018 | 09:41 AM
• Gold prices slipped as dollar recovered from 3-yr low • Oil little changed ahead of U.S. weekly cr...
18 Jan 2018 | 07:00 AM
The underlying sentiments continue to remain positive for the Indian markets. However, with indices ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 35.60 0.45
4,00,000 90.05 150.43 0.44
4,00,000 90.05 158.08 0.45
4,00,000 90.05 57.52 0.44
1,60,000 35.89 98.56 0.38

Shareholding Pattern

       
Promotors48.36%
Mutual Funds/UTI4.95%
FI/Banks0.32%
Insurance0.32%
FII24.87%
Government0.00%
Others4.29%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
5,462.25(0.55)
3280
 Sanofi India Ltd.
4,730.00(1.43)
3325
 Piramal Enterprises Ltd.
2,786.85(0.64)
3356
 Dr. Reddy`s Laboratories Ltd.
2,487.50(0.89)
3294

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.17.6536.7050.10
NIFTY(S&P CNX)505.95683.851,067.55
BSE SENSEX1,909.902,927.233,800.59
BSE 500717.991,157.761,797.10

Corporate Details

Key Personal
A K S Bhujanga Rao
Director & President (R&D and Tech.)
A K S Bhujanga Rao
President & Director
D Linga Rao
Director & President (Tech. Affairs)
Key Address
Registered Office
NATCO House Road # 2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar